Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Robert Hershberg
AddedFeb 15, 2024
UpdatedMay 31, 2026
Robert Hershberg

Robert Hershberg

Board Member, Adaptive Biotechnologies

CrunchbaseLinkedInThe Org

Robert Hershberg's Career

Adaptive Biotechnologies
Adaptive Biotechnologies

Seattle, WA, US

Board Member· Board
Cajal Neuroscience
Cajal Neuroscience

Seattle, WA, US

Board Member· Board
VentiRx Pharmaceuticals
VentiRx Pharmaceuticals

Seattle, WA, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Robert Hershberg's Career

Adaptive Biotechnologies
Adaptive Biotechnologies
Public$531.9M7902009Seattle, WA, US
Board Member· Board

Leadership at Adaptive Biotechnologies

Peter NeupertPeter NeupertBoard Member
Edus WarrenEdus WarrenBoard Member
Craig WeissmanCraig WeissmanBoard Member
Christopher CarlsonChristopher CarlsonCo-Founder
Katey Einterz OwenKatey Einterz OwenBoard Member
Harlan RobinsHarlan RobinsCo-Founder

Similar to Adaptive Biotechnologies

SeagenSeagenBothell, WA, USCancer Treatmentsest. 1997SeagenBothell, WA, US · est. 1997

Global biotech innovator developing cancer treatments.

Public · $1.7B3.3k
HI-BioHI-BioSan Francisco, CA, USBiotechest. 2021HI-BioSan Francisco, CA, US · est. 2021

HI-Bio pioneers precision medicine, targeting cellular drivers to treat immune-mediated diseases.

Series B · $215M48
Mission BioMission BioSouth San Francisco, CA, USMedical Devicesest. 2014Mission BioSouth San Francisco, CA, US · est. 2014

Mission Bio, a California-based medical organization, offers the unique Tapestri Platform for precise disease detection and treatment response in oncology.

Series D · $150.9M122
FluidigmFluidigmSouth San Francisco, CA, USBiotechnologyest. 1999FluidigmSouth San Francisco, CA, US · est. 1999

Standard BioTools Inc., based in South San Francisco, accelerates life sciences research with essential, standardized technologies.

Public615
Cajal Neuroscience
Cajal Neuroscience
Series A$96M1752020Seattle, WA, US
Board Member· Board

Leadership at Cajal Neuroscience

Ignacio Munoz-SanjuanIgnacio Munoz-SanjuanCEO
Huda ZoghbiHuda ZoghbiCo-Founder
Charles ZukerCharles ZukerCo-Founder
Andrew DervanAndrew DervanCo-Founder
Ian PeikonIan PeikonCo-Founder
Alex VaughanAlex VaughanCo-Founder

Similar to Cajal Neuroscience

CuraSen TherapeuticsCuraSen TherapeuticsSan Carlos, CA, USDrugsest. 2016CuraSen TherapeuticsSan Carlos, CA, US · est. 2016

CuraSen: A biotech firm innovating drugs for CNS and neurodegenerative diseases enhancement.

Series A · $95.9M38
NeuroX1NeuroX1Austin, TX, USDrug Discoveryest. 2021NeuroX1Austin, TX, US · est. 2021

NeuroX1: A computational startup designing novel compounds for neurodegenerative diseases using our proprietary platform.

Seed · $1.8M6
NeuroGenetic PharmaceuticalsNeuroGenetic PharmaceuticalsDel Mar, CA, USDrugs, Pharmaceuticalsest. 2009NeuroGenetic PharmaceuticalsDel Mar, CA, US · est. 2009

US-based NeuroGenetic Pharmaceuticals pioneers in developing innovative drugs to prevent neurodegenerative diseases.

Seed · $4M9
Reservoir NeuroscienceReservoir NeuroscienceEmeryville, CA, USTherapeuticsest. 2019Reservoir NeuroscienceEmeryville, CA, US · est. 2019

Reservoir Neuroscience: A biopharma company innovating novel therapeutic solutions.

Series A · $7.9M8
VentiRx Pharmaceuticals
VentiRx Pharmaceuticals
Acquired$104.5M02006Seattle, WA, US
Founder

Leadership at VentiRx Pharmaceuticals

Giovanni CaforioGiovanni CaforioBoard Member
Patrick HeronPatrick HeronBoard Member
Atul SaranAtul SaranBoard Member
Kent SnyderKent SnyderBoard Member
Ron LauferRon LauferBoard Member
Curtis WhiteCurtis WhiteBoard Member

Robert Hershberg's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Robert Hershberg

Rob HershbergRob HershbergBoard Member · Recursion PharmaceuticalsChad RobinsChad RobinsCEO · Adaptive BiotechnologiesMichael ArtingerMichael ArtingerBoard Member · Solaris VaccinesMaurice ZaudererMaurice ZaudererBoard Member · VaccinexDan SindelarDan SindelarCo-Founder · Keystone Bio